Molecular Mechanisms of HIV-1 Latency from a Chromatin and Epigenetic Perspective

IF 3.1 Q2 MICROBIOLOGY Current Clinical Microbiology Reports Pub Date : 2023-10-20 DOI:10.1007/s40588-023-00208-3
Bianca B. Jütte, Luca Love, J. Peter Svensson
{"title":"Molecular Mechanisms of HIV-1 Latency from a Chromatin and Epigenetic Perspective","authors":"Bianca B. Jütte, Luca Love, J. Peter Svensson","doi":"10.1007/s40588-023-00208-3","DOIUrl":null,"url":null,"abstract":"Abstract Purpose of Review The main obstacle to an HIV-1 cure is the reservoir of HIV-1 infected cells. While antiretroviral therapy (ART) eliminates the HIV-1 virus effectively, it does not target the reservoir. To eliminate infected cells, we need an improved understanding of the reservoir maintenance and reactivation mechanisms, including the influence of chromatin. Recent Findings The last years’ technological advances enable an in-depth study of the reservoir, uncovering subsets of infected cells, proviral integration sites, and single-cell nucleosome histone modifications. These revelations illustrate how the immune system and cell proliferation shape reservoirs under long-term ART. These forces create highly individual reservoirs that will require personalized treatment for their eradication. Summary A greater understanding of HIV-1 latency mechanisms, focusing on chromatin features, proviral reservoir dynamics, and inter-individual differences, can drive the development of more precise HIV-1 treatment strategies, ultimately achieving a globally available HIV-1 cure.","PeriodicalId":45506,"journal":{"name":"Current Clinical Microbiology Reports","volume":"8 4","pages":"0"},"PeriodicalIF":3.1000,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Clinical Microbiology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40588-023-00208-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Purpose of Review The main obstacle to an HIV-1 cure is the reservoir of HIV-1 infected cells. While antiretroviral therapy (ART) eliminates the HIV-1 virus effectively, it does not target the reservoir. To eliminate infected cells, we need an improved understanding of the reservoir maintenance and reactivation mechanisms, including the influence of chromatin. Recent Findings The last years’ technological advances enable an in-depth study of the reservoir, uncovering subsets of infected cells, proviral integration sites, and single-cell nucleosome histone modifications. These revelations illustrate how the immune system and cell proliferation shape reservoirs under long-term ART. These forces create highly individual reservoirs that will require personalized treatment for their eradication. Summary A greater understanding of HIV-1 latency mechanisms, focusing on chromatin features, proviral reservoir dynamics, and inter-individual differences, can drive the development of more precise HIV-1 treatment strategies, ultimately achieving a globally available HIV-1 cure.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从染色质和表观遗传学的角度看HIV-1潜伏期的分子机制
HIV-1治疗的主要障碍是HIV-1感染细胞的储存库。虽然抗逆转录病毒疗法(ART)可以有效地消除HIV-1病毒,但它并不针对病毒库。为了消除受感染的细胞,我们需要更好地了解储存库的维持和再激活机制,包括染色质的影响。近年来的技术进步使对病毒库的深入研究成为可能,揭示了感染细胞的亚群、原病毒整合位点和单细胞核小体组蛋白修饰。这些揭示说明了免疫系统和细胞增殖如何在长期抗逆转录病毒治疗下形成储库。这些力量产生了高度个性化的水库,需要个性化的治疗来消灭它们。更深入地了解HIV-1潜伏机制,重点关注染色质特征、前病毒库动力学和个体间差异,可以推动更精确的HIV-1治疗策略的发展,最终实现全球可用的HIV-1治愈。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.50
自引率
1.90%
发文量
9
期刊介绍: Current Clinical Microbiology Reports commissions expert reviews from leading scientists at the forefront of research in microbiology. The journal covers this broad field by dividing it into four key main areas of study: virology, bacteriology, parasitology, and mycology. Within each of the four sections, experts from around the world address important aspects of clinical microbiology such as immunology, diagnostics, therapeutics, antibiotics and antibiotic resistance, and vaccines. Some of the world’s foremost authorities in the field of microbiology serve as section editors and editorial board members. Section editors select topics for which leading researchers are invited to contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, which are highlighted in annotated reference lists. These timely reviews of the literature examine the latest scientific discoveries and controversies as they emerge and are indispensable to both researchers and clinicians. The editorial board, composed of more than 20 internationally diverse members, reviews the annual table of contents, ensures that topics address all aspects of emerging research, and where applicable suggests topics of critical importance to various countries/regions.
期刊最新文献
SARS-CoV-2 Resistance to Small Molecule Inhibitors. Integrating Genomic Data with the Development of CRISPR-Based Point-of-Care-Testing for Bacterial Infections. Intimate Relationship Between Stress and Human Alpha‑Herpes Virus 1 (HSV‑1) Reactivation from Latency. Bacterial and Fungal Keratitis: Current Trends in Its Diagnosis and Management Engineered Therapeutic Antibody Against SARS-CoV-2
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1